al-AbdullahI. H.; Anil KumarM. S.; Kelly-SullivanD.; AbounaG. M.Site for unpurified islet transplantation is an important parameter for determination of the outcome of graft survival and function.Cell Transplant.4: 297–305; 1995.
2.
Ar'RajabA.; HarrisR. B.; Khair-el-DinT. A.; SentementesJ. T.; LuC.; DawidsonI. J.Immunosuppressive effect of 2′-deoxycoformycin (Pentostatin) for rat islet allotransplantation.Cell Transplant.4: 315–321; 1995.
3.
ClaytonH. A.; LondonN. J.Survival and function of islets during culture.Cell Transplant.5: 1–12; 1996.
4.
CoddingtonD. A.; YangH.; RowdenG.; ColpP.; IssekutzT. B.; WrightJ. R.Jr.Islet allograft rejection in rats: A time course study characterizing adhesion molecule expression, MHC expression, and infiltrate immunophenotypes.Cell Transplant.7: 285–297; 1998.
5.
ContractorH. H.; JohnsonP. R.; ChadwickD. R.; RobertsonG. S.; LondonN. J.The effect of UW solution and its components on the collagenase digestion of human and porcine pancreas.Cell Transplant.4: 615–619; 1995.
6.
HaraY.; TaniguchiH.; IsobeM.Effect of antiadhesion antibodies on pancreatic islet xenotransplantation.Cell Transplant.4: S55–77; 1995.
7.
HayashiH.; InoueK.; AungT.; TunT.; YuanjunG.; WenjingW.; ShinoharaS.; KajiH.; DoiR.; SetoyamaH.; KatoM.; ImamuraM.; MaetaniS.; MorikawaN.; IwataH.; IkadaY.; MiyazakiJ.Application of a novel B cell line MIN6 to a mesh-reinforced polyvinyl alcohol hydrogel tube and three-layer agarose microcapsules: An in vitro study.Cell Transplant.5: S65–69; 1996.
8.
HouwingH.; HilbrandsL. G.; Van SuylichemP. T.; BrugginkJ. E.; SteffensA. B.; StrubbeJ. H.Control of insulin secretion and glucose homeostasis in exercising diabetic rats with intrasplenic or kidney subcapsular islet grafts.Cell Transplant.6: 413–422; 1997.
9.
HouwingH.; Van AsperenR. M.; Van der ZeeE. A.; Van SuylichemP. T.; OestreicherA. B.; SteffensA. B.; StrubbeJ. H.Noradrenergic and cholinergic reinnervation of islet grafts in diabetic rats.Cell Transplant.5: 21–30; 1996.
10.
JohnsonP. R.; WhiteS. A.; LondonN. J.Collagenase and human islet isolation.Cell Transplant.5: 437–452; 1996.
11.
KawakamiY.; InoueK.; TunT.; HayashiH.; SetoyamaH.; GuY. J.; CuiW. X.; ImamuraM.; IwataH.; IkadaY.Prolonged effect of troglitazone (CS-045) on xenograft survival of hybrid artificial pancreas.Cell Transplant.6: 547–550; 1997.
12.
KawakamiY.; InoueK.; HayashiH.; WangW. J.; SetoyamaH.; GuY. J.; ImamuraM.; IwataH.; IkadaY.; NozawaM.; MiyazakiJ.Subcutaneous xenotransplantation of hybrid artificial pancreas encapsulating pancreatic B cell line (MIN6): Functional and histological study.Cell Transplant.6: 541–545; 1997.
13.
KenmochiT.; MiyamotoM.; MullenY.Protection of mouse islet isografts from nonspecific inflammatory damage by recipient treatment with nicotinamide and 15-deoxyspergualin.Cell Transplant.5: 41–47; 1996.
14.
KinT.; NakajimaY.; KanehiroH.; AomatsuY.; YoshimuraA.; TakiJ.; KoS.; YaguraK.; OyamaT.; OhashiK.; NakanoH.Effect of complement activation in human serum on isolated porcine islets.Cell Transplant.5: S45–47; 1996.
15.
KlockG.; KowalskiM. B.; HeringB. J.; EidenM. E.; WeidemannA.; LangerS.; ZimmermannU.; FederlinK.; BretzelR. G.Fractions from commercial collagenase preparations: Use in enzymic isolation of the islets of Langerhans from porcine pancreas.Cell Transplant.5: 543–551; 1996.
16.
KulsengB.; ThuB.; EspevikT.; Skjak-BraekG.Alginate polylysine microcapsules as immune barrier: Permeability of cytokines and immunoglobulins over the capsule membrane.Cell Transplant.6: 387–394; 1997.
17.
LakeyJ. R.; WarnockG. L.; AoZ.; RajotteR. V.Bulk cryopreservation of isolated islets of Langerhans.Cell Transplant.5: 395–404; 1996.
18.
LakeyJ. R.; ZiegerM. A.; WoodsE. J.; LiuJ.; CritserJ. K.Hypoosmotic exposure of canine pancreatic digest as a means to purify islet tissue.Cell Transplant.6: 423–428; 1997.
19.
LakeyJ. R.; WarnockG. L.; RajotteR. V.Comparison of methods used for the removal of DMSO following cryopreservation and the development of an automated protocol.Cell Transplant.6: 163–172; 1997.
LeowC. K.; GrayD. W.; MorrisP. J.Successful reversal of diabetes by single donor isologous islet transplantation in a mouse model.Cell Transplant.6: 429–430; 1997.
22.
MendolaJ. F.; CorominolaH.; EsmatjesE.; SaenzA.; Fernandez-CruzL.; GomisR.Effect of fusidic acid on pancreatic islet allograft rejection.Cell Transplant.6: 39–45; 1997.
23.
MendolaJ. F.; CongetI.; ManzanaresJ. M.; CorominolaH.; VinasO.; BarceloJ.; GomisR.Follow-up study of the revascularization process of purified rat islet beta-cell grafts.Cell Transplant.6: 603–612; 1997.
24.
MendolaJ. F.; GoityC.; EsmatjesE.; SaenzA.; Fernandez-CruzL.; GomisR.Cyclosporine does not inhibit the process of revascularization of pancreatic islet transplantation.Cell Transplant.6: 69–76; 1997.
25.
MonroyB.; HonigerJ.; DarquyS.; ReachG.Use of polyethyleneglycol for porcine islet cryopreservation.Cell Transplant.6: 613–621; 1997.
26.
MorsianiE.; RozgaJ.; DellagiacomaG.; DemetriouA. A.Repeated intraportal injections of subtherapeutic islet cell isografts restore normoglycemia in streptozotocin-diabetic rats.Cell Transplant.6: 17–22; 1997.
27.
OettingerH. F.; Rodrigue-WayA.; BousquetJ. J.; EdgeA. S.Porcine repeat element DNA: In situ detection of xenotransplanted cells.Cell Transplant.4: 253–256; 1995.
28.
OhgawaraH.; MiyazakiJ.; NakagawaY.; SatoS.; KaribeS.; AkaikeT.Xenoimplantation using a diffusion chamber with a B-cell line (MIN6) as a bioartificial endocrine pancreas (Bio-AEP).Cell Transplant.5: S71–73; 1996.
29.
OhgawaraH.; MiyazakiJ.; KaribeS.; TashiroF.; AkaikeT.; HashimotoY.Embedded-culture of pancreatic beta-cells derived from transgenic mouse insulinoma as a potential source for xenotransplantation using a diffusion chamber.Cell Transplant.4: 307–313; 1995.
30.
OkugawaK.; FukudaY.; SakimotoH.; NishiharaM.; TashiroH.; UrushiharaT.; IkedaM.; IwataH.; DohiK.Intermittent intraperitoneal implantation of islets in rat islet transplantation.Cell Transplant.5: S51–53; 1996.
31.
RayatG. R.; KorbuttG. S.; ElliottJ. F.; RajotteR. V.Survival and function of syngeneic rat islet grafts placed within the thymus versus under the kidney capsule.Cell Transplant.6: 597–602; 1997.
32.
RicordiC.; MuraseN.; RastelliniC.; BehbooR.; DemetrisA. J.; StarzlT. E.Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation.Cell Transplant.5: 53–55; 1996.
33.
RicordiC.The structure of scientific revolutions: A cell transplant perspective.Cell Transplant.4: 357–360; 1995.
SamejimaT.; YamaguchiK.; IwataH.; MorikawaN.; IkadaY.Gelatin density gradient for isolation of islets of Langerhans.Cell Transplant.7: 37–45; 1998.
36.
SatoS.; OhgawaraH.; NakagawaY.; KatagiriN.; FuchinoueS.; TeraokaS.A simple method for cryopreservation of purified adult pig pancreatic cells.Cell Transplant.5: S49–50; 1996.
37.
SelawryH. P.; WangX.; AlloushL.Sertoli cell-induced defects on functional and structural characteristics of isolated neonatal porcine islets.Cell Transplant.5: 517–524; 1996.
38.
ShapiroA. M.; HaoE.; RajotteR. V.; KnetemanN. M.High yield of rodent islets with intraductal collagenase and stationary digestion—a comparison with standard technique.Cell Transplant.5: 631–638; 1996.
39.
ShiC. L.Effects of caffeine and acetylcholine on glucose-stimulated insulin release from islet transplants in mice.Cell Transplant.6: 33–37; 1997.
40.
ShirokiR.; MohanakumarT.; ScharpD. W.Analysis of the serological and cellular sensitization induced by encapsulated human islets transplantation in type I and type II diabetes patients.Cell Transplant.4: 535–538; 1995.
41.
SimeonovicC. J.; BrownD. J.; TownsendM. J.; WilsonJ. D.Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression.Cell Transplant.5: 525–541; 1996.
42.
SlavinS.; WeissL.; XiaW.; GrossD. J.Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide).Cell Transplant.5: 627–630; 1996.
43.
SuzukiK.; Bonner-WeirS.; Hollister-LockJ.; ColtonC. K.; WeirG. C.Number and volume of islets transplanted in immunobarrier devices.Cell Transplant.7: 47–52; 1998.
44.
SuzukiK.; Bonner-WeirS.; HollisterJ.; WeirG. C.A method for estimating number and mass of islets transplanted within a membrane device.Cell Transplant.5: 613–625; 1996.
45.
TormoM. A.; Leon-QuintoT.; SaulnierC.; BailbeD.; SerradasP.; PorthaB.Insulin secretion and glucose tolerance after islet transplantation in rats with noninsulin-dependent diabetes induced by neonatal streptozotocin.Cell Transplant.6: 23–32; 1997.
46.
TuchB. E.; MadridJ. C.; SummersE.; SmithM. S.Production and characterization of fetal sheep pancreatic islet-like cell clusters.Cell Transplant.5: 491–498; 1996.
47.
TuchB. E.; MadridJ. C.Development of fetal sheep pancreas after transplantation into athymic mice.Cell Transplant.5: 483–489; 1996.
48.
TunT.; InoueK.; HayashiH.; AungT.; GuY. J.; DoiR.; KajiH.; EchigoY.; WangW. J.; SetoyamaH.; ImamuraM.; MaetaniS.; MorikawaN.; IwataH.; IkadaY.A newly developed three-layer agarose microcapsule for a promising biohybrid artificial pancreas: Rat to mouse xenotransplantation.Cell Transplant.5. S59–63; 1996.
49.
van der BurgM. P.; van SuylichemP. T.; GuicheritO. R.; FrolichM.; LemkesH. H.; GooszenH. G.Glucoregulation after canine islet transplantation: Contribution of insulin secretory capacity, insulin action, and the entero-insular axis.Cell Transplant.6: 497–503; 1997.
50.
Vos-ScheperkeuterG. H.; van SuylichemP. T.; VonkM. W.; WoltersG. H.; van SchilfgaardeR.Histochemical analysis of the role of class I and class II Clostridium histolyticum collagenase in the degradation of rat pancreatic extracellular matrix for islet isolation.Cell Transplant.6: 403–412; 1997.
51.
WangS.; BeattieG. M.; MallyM. I.; CirulliV.; Itkin-AnsariP.; LopezA. D.; HayekA.; LevineF.Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas.Cell Transplant.6: 59–67; 1997.